ClinicalTrials.gov
public full text
Public Domain
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
This is a prospective pharmacogenomics study of mood stabilizer response. The goal of this work is to identify genes associated with good response of patients with bipolar disorder to two commonly used mood stabilizing agents, lithium and valproate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study#224186
- Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders#829664
- Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting#1371753
- Children's Bipolar Network Treatment Trial I#1196655
- Evaluation of the Genetics of Bipolar Disorder#827220
Record · ID 1369922
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive